From Gene to Therapy: Is Coronary Artery Disease and Dilated Cardiomyopathy One or More Diseases? Editorial Pages: 67 - 67
Atherogenetically Relevant Cells Support Continuous Growth of Chlamydia Pneumoniae Matthias MaassJens GieffersWerner Solbach Pages: 68 - 72
Immune Responses to Chlamydia Antigens in Atherosclerosis John S.H. GastonAllison J. CurryPeter J. Kirkpatrick Pages: 73 - 78
Chlamydia Pneumoniae Infection is Not an Independent Risk Factor for Arterial Disease Werner HaberboschChristian Jantos Pages: 79 - 83
Pathogenesis of Atherosclerosis: Infectious versus Immune Pathogenesis A New Concept Sucharit Bhakdi Pages: 84 - 86
Atherosclerosis – An Autoimmune Disease Due to an Immune Reaction against Heat-Shock Protein 60 Georg Wick Pages: 87 - 90
Restenosis after Percutaneous Coronary Interventions and Infection Matthias HerzumJuergen R. SchaeferBernhard Maisch Pages: 91 - 94
Transplant Vasculopathy: a Model for Coronary Artery Disease? Mario C. DengGabriele PlenzHider A. Baba Pages: 95 - 99
Inflammation and Acute Coronary Syndromes Luigi M. BiasucciGiovanna LiuzzoAttilio Maseri Pages: 108 - 112
Strategies to Optimize CAD Prevention in Modern Cardiology The “Marburg CAD Prevention Project” Juergen R. SchaeferBernd SimonBernhard Maisch Pages: 113 - 116
HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering? Winfried MärzHeinrich Wieland Pages: 117 - 125
The VEGF Splice Variants: Properties, Receptors, and Usage for the Treatment of Ischemic Diseases Zoya PoltorakTzafra CohenGera Neufeld Pages: 126 - 129
Potassium Channel Openers and Blockers in Coronary Artery Disease Comparison to Betablockers and Calcium Antagonists Veselin MitrovicEckart OehmChristian Hamm Pages: 130 - 142
